The characteristics of the patients
Case . | Sex . | Age, y . | Infected cell . | Clonality of the infected cells . | Clinical findings . | EBV-DNA load of each fraction of PBMCs, copies/μg DNA . | Pathological diagnosis . | The rate of the EBV-infected cell fractions in PBMCs, % . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total PBMCs . | CD4+ cells . | CD8+ cells . | CD56+ cells . | Others . | ||||||||
CD4-1 | F | 25 | CD4 | Monoclonal | Fever, HMB | 7.0 × 104 | 2.2 × 105 | ND | ND | ND | CAEBV | 71.2 |
CD4-2 | F | 62 | CD4 | Monoclonal | Fever, LD | 3.2 × 104 | 4.6 × 105 | ND | ND | ND | ND* | 23.5 |
CD4-3 | M | 33 | CD4 | Monoclonal | Fever | 9.2 × 103 | 1.0 × 105 | ND | ND | ND | CAEBV | 54.2 |
CD8-1 | F | 21 | CD8 | Monoclonal | Fever, LD | 1.8 × 103 | ND | 6.0 × 102 | ND | ND | CAEBV | 50.0 |
CD8-2 | F | 64 | CD8 | Monoclonal | Fever, LD | 2.6 × 105 | ND | 1.2 × 106 | ND | ND | CAEBV | 51.0 |
CD8-3 | F | 64 | CD8 | Monoclonal | Fever, LD | 4.7 × 104 | ND | 1.7 × 104 | ND | ND | CAEBV | 51.1 |
CD56-1 | F | 18 | CD56 | Monoclonal | Fever, HMB | 5.2 × 104 | ND | ND | 1.1 × 106 | ND | CAEBV | 3.8 |
CD56-2 | F | 48 | CD56 | Monoclonal | Fever, LD | 8.6 × 104 | ND | ND | 1.0 × 105 | ND | ND* | 10.0 |
CD56-3 | M | 23 | CD56 | Monoclonal | Fever, colitis | 2.9 × 103 | ND | ND | 2.1 × 104 | ND | ND* | 4.2 |
CD4/56-1 | F | 18 | CD4/56 | Monoclonal | Fever, LD | 6.0 × 104 | 1.7 × 106 | ND | 7.1 × 106 | ND | CAEBV | 35.2 (CD4), 2.3 (CD56) |
Case . | Sex . | Age, y . | Infected cell . | Clonality of the infected cells . | Clinical findings . | EBV-DNA load of each fraction of PBMCs, copies/μg DNA . | Pathological diagnosis . | The rate of the EBV-infected cell fractions in PBMCs, % . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total PBMCs . | CD4+ cells . | CD8+ cells . | CD56+ cells . | Others . | ||||||||
CD4-1 | F | 25 | CD4 | Monoclonal | Fever, HMB | 7.0 × 104 | 2.2 × 105 | ND | ND | ND | CAEBV | 71.2 |
CD4-2 | F | 62 | CD4 | Monoclonal | Fever, LD | 3.2 × 104 | 4.6 × 105 | ND | ND | ND | ND* | 23.5 |
CD4-3 | M | 33 | CD4 | Monoclonal | Fever | 9.2 × 103 | 1.0 × 105 | ND | ND | ND | CAEBV | 54.2 |
CD8-1 | F | 21 | CD8 | Monoclonal | Fever, LD | 1.8 × 103 | ND | 6.0 × 102 | ND | ND | CAEBV | 50.0 |
CD8-2 | F | 64 | CD8 | Monoclonal | Fever, LD | 2.6 × 105 | ND | 1.2 × 106 | ND | ND | CAEBV | 51.0 |
CD8-3 | F | 64 | CD8 | Monoclonal | Fever, LD | 4.7 × 104 | ND | 1.7 × 104 | ND | ND | CAEBV | 51.1 |
CD56-1 | F | 18 | CD56 | Monoclonal | Fever, HMB | 5.2 × 104 | ND | ND | 1.1 × 106 | ND | CAEBV | 3.8 |
CD56-2 | F | 48 | CD56 | Monoclonal | Fever, LD | 8.6 × 104 | ND | ND | 1.0 × 105 | ND | ND* | 10.0 |
CD56-3 | M | 23 | CD56 | Monoclonal | Fever, colitis | 2.9 × 103 | ND | ND | 2.1 × 104 | ND | ND* | 4.2 |
CD4/56-1 | F | 18 | CD4/56 | Monoclonal | Fever, LD | 6.0 × 104 | 1.7 × 106 | ND | 7.1 × 106 | ND | CAEBV | 35.2 (CD4), 2.3 (CD56) |
F, female; HMB, hypersensitivity to mosquito bites; LD, liver dysfunction; M, male; ND, not detected.
The diagnosis of CAEBV was made by clinical findings and detecting EBV-infected T or NK cells using unfixed PB as shown in “Materials and methods.”